53
National Institute of Public Health Cuernavaca Mexico Costs and Costing Costs and Costing Cost Benefit Analysis Cost Benefit Analysis Cost Effectiveness Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008 Cape Town

National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Embed Size (px)

Citation preview

Page 1: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

NationalInstitute of Public Health

CuernavacaMexico

Costs and CostingCosts and CostingCost Benefit Analysis Cost Benefit Analysis

Cost Effectiveness Cost Effectiveness Analysis Analysis

Stefano BertozziMarch, 2008Cape Town

Page 2: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Costs and CostingCosts and Costing

Page 3: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Costs perspectives: Costs perspectives: Accountants vs. Accountants vs.

EconomistsEconomists

• Value of fixed assets vs. Fixed Cost

• Total Cost (TC)= Cost of producing a specific amount of product/service

• Fixed Cost (FC)= Cost that does not vary with the quantity produced in the short run (one year)

• Variable Cost (VC)= Cost that varies with the quantity produced

Page 4: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Costs perspectives: Costs perspectives: Accountants vs. Accountants vs.

EconomistsEconomists

• Value of assets vs. Fixed Cost

• Depreciation vs. Discounting

Page 5: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

0

10

20

30

40

50

60

70

80

90

100

1 5 10 15 20 25 30

0%; Total 3,000

3%; Total 2,019

10%; Total 1,037

Page 6: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Costs perspectives: Costs perspectives: Accountants vs. Accountants vs.

EconomistsEconomists

• Value of assets vs. Fixed Cost

• Depreciation vs. Discounting

• Financial Cost vs. Opportunity Cost

The cost of any activity measured in terms of the benefit forgone from the next best alternative

Page 7: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Costs perspectives: Costs perspectives: Accountants vs. Accountants vs.

EconomistsEconomists

• Value of assets vs. Fixed Cost

• Depreciation vs. Discounting

• Financial Cost vs. Opportunity Cost

• Minimize leaks and auditing problems vs. Maximize efficiency

• Average Cost vs. Marginal Cost

• Average Cost: total cost /n• Marginal Cost:

total cost [n] – total cost [n-1]

Page 8: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

0

5

10

15

20

25

1 5 10 15 20 25 30 35 40 45

units number

Co

st

MarginalCost

Average Cost

Page 9: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

¿Why cost?¿Why cost?

• Evaluate efficiency in two equivalent programs – Which one provides greater benefits,

given a fixed amount of resources

• Identify principal cost categories, to guide managers towards potential savings

• Forecast costs

• Set user fees

• Perform cost-benefit or cost-effectiveness analyses

Page 10: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

¿What is cost?¿What is cost?

It is the value of the resources used to produce something (not necessarily the amount paid for those resources)

Page 11: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Key costing aspectsKey costing aspects

A) Perspective

B) Time Frame

C) Analytic horizon

D) Data availability

Page 12: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

A) Perspective A) Perspective • User/beneficiary: (e.g. transport costs, user fees,

opportunity cost for the family, etc.)

• Provider: (e.g. treatment and hospitalization costs; costs of running a school)

• Social: all costs, regardless of who pays, including positive and negative externalities (non-compensated work, changes in productivity, in the savings rate, etc.)

Page 13: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

B) Time FrameB) Time Frame

• Period of study for data collection

• Need to capture temporal variation (typically one year)

Page 14: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

C) Analytic HorizonC) Analytic Horizon

• Period of time in which costs and effects are modeled– For HIV, typically a lifetime, if not more…

Page 15: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Cost estimation can be Cost estimation can be divided into three parts:divided into three parts:

• Identification of the relevant costs

• Quantity of resources used (Qs)

• Value of resources used (C=P*Q)

P= price Q= quantity

Page 16: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Definitions and Costs Definitions and Costs CategorizationCategorization

Page 17: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Costs & MoneyCosts & Money

• Not all costs are expenses– Caring/nursing time– Time of volunteers– Donations

• Costs included depend on the perspective

Page 18: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Net CostsNet Costs• The net costs of one intervention are:

(Total Costs of the intervention) – (Value of savings generated)

e.g. INTERVENTION: PCP Prophylaxis

Costs Savings

► Drug (Bactrim) ► Nurse/Physician time► Logistics: per diems expenses, transport, gasoline…

Averted hospitalizations

Averted productivity losses (home nursing, averted deaths)

Page 19: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Two types of inputs to Two types of inputs to classifyclassify

• recurrent inputs: inputs that are used in less than one year

• capital inputs : inputs that last more than one year

Page 20: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Cost - Benefit AnalysisCost - Benefit Analysis

Page 21: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

What is CBA?What is CBA?

• Values the consequences of an intervention in monetary terms

• Enables comparison of interventions in different sectors (e.g. health vs. education vs. infrastructure)

• If a project as a whole produces more benefits than costs, it is worth doing it. Otherwise, no.

Page 22: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Cost-Benefit AnalysisCost-Benefit Analysis

Implementation Obstacles :

– Difficult and controversial to allocate monetary value to changes in:

Morbidity and mortality (value of a life…)

Page 23: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Cost – Effectiveness Cost – Effectiveness AnalysisAnalysis

Page 24: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Cost – Effectiveness Cost – Effectiveness Analysis Analysis

• Only useful when comparing costs and consequences of two or more alternatives

• Only useful when the competing alternatives produce a common result

e.g.: – HIV infections averted – years of additional life (on ART)– child deaths from malaria

Page 25: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Cost – Effectiveness Cost – Effectiveness AnalysisAnalysisIdentify a common outcome for

the alternatives to be compared

Examples of effectiveness measures

Intervention Effectiveness Measures

Male circumcision HIV Incidence in (-) menHIV incidence in partners of (+) men

Police HR, S&D training Episodes of discrimination

“Accompagnateur” Adherence, Survival

Raltegravir in 1st line therapy % achieving VS in 3moDuration of viral supression

Page 26: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

IDENTIFICATION OF RELEVANT ALTERNATIVES

• CEA makes no sense when analyzing only one alternative

• It estimates cost per unit of effect

• This value alone does not tell you if an intervention is a “good buy”, but…

$/DALY

Steps to consider in CEA…Steps to consider in CEA…

Page 27: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

IDENTIFICATION OF RESULT MEASURES

• Intermediate

– Condom use at last 3 intercourse

• Final

– Fertility

– STI incidence

– HIV incidence

Steps to consider in CEA…Steps to consider in CEA…

Page 28: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

• Adverse effects of the intervention

• Costing

– Program/Intervention Costs

– Averted costs

– Externalities (e.g. productivity losses of third parties)

Steps to consider in CEA…Steps to consider in CEA…

Page 29: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

DesignDesign

• Conceptual Model– Flow diagram of the relevant interventions– Decision Tree or other way to model

the process (Markov Model)– The quality of the results depends on

the quality of the model– Parameter uncertainty can be readily

addressed, not so for uncertainty related to structure of the model

Page 30: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Intervention

Male Circ

No MC

Infected

Infected

Healthy

Healthy

Survive

Die

Die

Survive

Page 31: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

% ADHERENCIA

100%

Average clinical benefit as a function of adherence

Vit A

ART

Page 32: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Sensitivity Analysis Sensitivity Analysis

• Model variables have different levels of uncertainty

• In absence of empirical data, one must make informed assumptions (e.g. about the effectiveness of new technologies)

• When there are methodological debates different scenarios can be modeled (e.g. discount rate, productivity losses)

Page 33: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Sensitivity AnalysisSensitivity Analysis

• Explores the sensitivity of the model’s results to variation in values of input parameters

• Tests the robustness of the conclusions by varying uncertain parameters across their “plausible” range

Page 34: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Types of Sensitivity Types of Sensitivity Analysis Analysis

• Univariate

• Multivariate– Scenarios (optimistic, baseline, pessimistic)

• Probabilistic

• Threshold Analysis

Page 35: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Cost-Effectiveness Cost-Effectiveness Measures Measures

• Cost per unit of produced effect

• A lower cost per unit is preferred

Page 36: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

0

100

200

300

400

500

600

0 50 100 150 200 250

FIGURE 5.5 Drummond

Effects

Co

sts

$500/200 cases prevented = 2.5 on average

$100/10 cases= 10 incremental

Page 37: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Interpretation of Cost-Interpretation of Cost-Effectiveness measuresEffectiveness measures

• Dominance– Program A dominates B when its

effectiveness is greater and its cost lower than program B

Page 38: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

0

100

200

300

400

500

600

0 50 100 150 200 250

FIGURE 5.5 Drummond

Effects

Co

sts

A

B

Page 39: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008
Page 40: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

If ART has no impact on If ART has no impact on prevention...prevention...

$50

If ART If ART helpshelps prevention... prevention...Government cost

$19

$200

$150

$100

$0

$50

$100

$150

$200

Adhere MTCT+ BPL

$168

BPL+Dis BPL+TM

$180$145

$163

US$ per life year saved

US$ per life year lost

If ART If ART slows slows prevention...prevention...

Page 41: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

But… not only should we know But… not only should we know WHATWHAT to implement, but also, to implement, but also, HOW.HOW.

Cost-benefit and cost-Cost-benefit and cost-effectiveness analyses help to effectiveness analyses help to decide which basket of decide which basket of interventions is the best to interventions is the best to achieve a specific objective.achieve a specific objective.

Page 42: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

¿Why cost?¿Why cost?

• Evaluate efficiency in two equivalent programs – Which one provides greater benefits,

given a fixed amount of resources

• Identify principal cost categories, to guide managers towards potential savings

• Forecast costs

• Set user fees

• Perform cost-benefit or cost-effectiveness analyses

Page 43: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Efficient Allocation vs. Efficient Allocation vs. Efficient Production Efficient Production

• Allocative efficiency – Allocate resources to those interventions

that provide the maximum “value for money”

– CBA & CEA

• Technical Efficiency– Make the most of the allocated funds to

each intervention– Efficiency Analysis and its determinants

Page 44: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Production Function and Production Function and Allocative EfficiencyAllocative Efficiency

X

Y

X1

Y1

Y2

Benefit

Investment

Intervention 1

Intervention 2

Page 45: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Allocative EfficiencyAllocative Efficiency

• Cost-effectiveness analyses typically assume:– Results are reproducible in

different contexts and scales– Interventions are implemented

at their efficiency frontier

• A “cost-effective” intervention can become very “cost-ineffective” if implemented inefficiently

Page 46: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

X

Y

X1

Y1

Y2

Y3

Benefit

Investment

Production Function and Production Function and Technical EfficiencyTechnical Efficiency

Page 47: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

66

Programs poorly managed: Enormous variation in unit costs

$1

$10

$100

$1000

0 10 100 1000 10,000

Annual Clients Completing VCT (scale)

Co

st p

er V

CT

Co

mp

lete

d (

un

it c

ost

)

MexicoUgandaRussiaIndiaSouth Africa

66

Page 48: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

67

Programs poorly managed: Enormous variation in unit costs

$1

$10

$100

$1000

0 10 100 1000 10,000

Annual Clients Completing VCT (scale)

Co

st p

er V

CT

Co

mp

lete

d (

un

it c

ost

)

MexicoUgandaRussiaIndiaSouth Africa

67

Page 49: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

68

Programs poorly managed: Enormous variation in unit costs

$1

$10

$100

$1000

0 10 100 1000 10,000

Annual Clients Completing VCT (scale)

Co

st p

er V

CT

Co

mp

lete

d (

un

it c

ost

)

MexicoUgandaRussiaIndiaSouth Africa

68

Page 50: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

0

20,000

40,000

60,000

80,000

100,000

120,000

VCT performed Potential VCT at efficiency frontier

Technical efficiency in VCT: Technical efficiency in VCT: 17 sites in Mexico17 sites in Mexico

Page 51: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Potential gains from technical Potential gains from technical efficiency improvementsefficiency improvements

• Possible to greatly increase social welfare

just by improving the technical efficiency of

the interventions/programs already funded

• In many cases the benefit may be greater

than that obtainable with a shift to a more

“cost-effective” mix of interventions (allocation

efficiency)

Page 52: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

No program will be efficient if it is not well managed – and one can’t manage well what one can’t measure

Page 53: National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008

Stefano M Bertozzi

[email protected]

MANY THANKS